InvestorsHub Logo
Post# of 252426
Next 10
Followers 30
Posts 4136
Boards Moderated 0
Alias Born 07/25/2007

Re: dewophile post# 246516

Sunday, 04/23/2023 11:23:19 AM

Sunday, April 23, 2023 11:23:19 AM

Post# of 252426

As you know there have been multiple attempts at a universal flu vaccine using conserved epitopes. This is more of a shotgun approach. The problem is you need to increase the dose for every epitope so unless you can get a very low effective dose per antigen you give up tolerability.



Yes. But you also have to consider that while not a perfect match, there might be some weak cross-antigenicity to an epitope that could provide some protection or at least partially protect the immune system. That is more likely with 20+ variants than say 3 or 4 in current shots. That isn't ideal but might be better than nothing.

As you know there have been multiple attempts at a universal flu vaccine using conserved epitopes.



Yes. I believe the Wistar Institute was working one on but I haven't heard anything in a long while form them. I just did a quick search but this is behind a paywall.

https://jamanetwork.com/journals/jama/article-abstract/2795046



I do think mRNA is the future for flu now because of speed. You can create a vaccine in record time so you can wait until the strains that are circulating are known with better certainty.



I agree completely. As far as Moderna's failure, I didn't expand on my comment but yes, I saw it was due to weaker protection against B strains. Thanks for your detailed commentary.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.